Results for tag: "Erleada"

Erleada is a prescription drug used to treat prostate cancer in men. It is a type of androgen receptor inhibitor, which works by blocking the action of male hormones that can cause prostate cancer cells to grow. Erleada is used in combination with other treatments, such as radiation therapy or surgery, to help slow the growth of prostate cancer. It is also used to treat advanced prostate cancer that has spread to other parts of the body. Erleada is approved by the U.S. Food and Drug Administration (FDA) for the treatment of prostate cancer. The Erleada market is a rapidly growing segment of the prostate cancer drug market. It is a highly competitive market, with several companies offering similar products. Companies in the Erleada market include Astellas Pharma, Janssen Pharmaceuticals, and Pfizer. These companies are focused on developing and marketing drugs that can help patients with prostate cancer. They are also investing in research and development to create new treatments and therapies for prostate cancer. Show Less Read more